MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA
- 26 July 2011
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 27 (11) , 1877-1883
Abstract
Purpose Promoter methylation of the O6-methylguanine-DNA-methyltransferase (MGMT) gene is widely recognized as an important predictive factor in the treatment of glioblastoma (GBM) patients with temozolomide. However, data regarding the methylation status of the MGMT promoter in pediatric GBM are yet to be elucidated. Methods Nineteen tissue samples of pediatric GBM were evaluated for the MGMT promoter methylation status using methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA). Methylation status was also evaluated using methylation-specific polymerase chain reaction (MSP) for 17 of the 19 patients. The correlation between MGMT promoter methylation and clinical outcome was assessed. Results Three of the 19 patients (16%) showed methylation of the MGMT promoter, according to MS-MLPA, as did 1 of the 17 (6%), according to MSP. The methylation status did not seem to have a definite effect on clinical outcome. Conclusions Pediatric GBMs rarely have methylated MGMT promoters. With a better clinical outcome and lower methylation rate than their adult counterparts, it may be suggested that, for pediatric GBM, MGMT promoter methylation does not play a significant role as a prognostic factor.Keywords
This publication has 25 references indexed in Scilit:
- Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patientsNeuro-Oncology, 2010
- Long-term outcomes in children with glioblastomaJournal of neurosurgery. Pediatrics, 2010
- Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology groupPediatric Blood & Cancer, 2010
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaNeuro-Oncology, 2009
- Pediatric glioblastomas: A histopathological and molecular genetic studyNeuro-Oncology, 2009
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumorsCancer, 2007
- Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged SurvivalClinical Cancer Research, 2007
- O6-Methylguanine-DNA Methyltransferase Expression Strongly Correlates With Outcome in Childhood Malignant Gliomas: Results From the CCG-945 CohortJournal of Clinical Oncology, 2006
- Long-Term Survival in Patients with Glioblastoma MultiformeNeurosurgery, 1993
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993